Tesla (NASDAQ: TSLA) board chair Robyn Denholm has sold approximately $33.7 million worth of Tesla stock, according to a recent SEC filing. Denholm, who has held the position since 2018, offloaded 112,390 shares. This follows a similar sale last month, where she sold the same number of shares for around $43.2 million.
The stock sale comes as Tesla's board faces scrutiny over executive compensation. Earlier this year, Denholm and other Tesla directors received court approval for a settlement worth up to $919 million, requiring them to return compensation to resolve claims of excessive pay between 2017 and 2020. During this period, Tesla’s stock surged, making stock options received by directors significantly more valuable.
Denholm previously testified in Elon Musk’s $56 billion pay package lawsuit, revealing that her tenure at Tesla had earned her around $280 million. Tesla’s board, which includes Musk’s brother Kimbal Musk, has often been criticized for its close ties to the billionaire CEO.
Meanwhile, Musk has expanded his influence beyond Tesla. President Donald Trump recently appointed him as head of the Department of Government Efficiency, assigning him to tackle government spending. This move aligns with broader efforts by the White House to cut costs, including thousands of job reductions.
Tesla’s stock has dropped about 13% since the November 5 elections, reflecting ongoing market volatility and concerns over governance. Investors remain watchful as regulatory and corporate challenges continue to shape the company’s trajectory.


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



